drugset / Trial / NCT05183841

Bronchodilators on the Exercise Capacity of Bronchiectasis Patients

NCT05183841

RandomizedCrossoverDouble-blindTreatment

Summary

The bronchodilators (BD) have been widely used in bronchiectasis (BCE) therapeutic and have been shown to be effective in improving exercise capacity in patients with chronic obstructive pulmonary disease and asthma. However the BD effect on the exercise capacity of patients with BCE is poorly known. Besides, the respiratory mechanics pattern of the patients with BCE is not known nor its association with their physical activity level (PAL). Therefore, the hypothesis of this study is that BD are effective in improving exercise capacity of patients with BCE. The authors also propose to characterize the respiratory mechanics of the patients with BCE and to evaluate their PAL and its association with quality of life, as secondary aims.

Timeline

Start
2022-04-14
Primary completion
2024-11
Completion
2025-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenoterol Unknown 50 ug Inhaled
Comparator Ipratropium Small molecule 20 ug Inhaled

Indications